Gyre Therapeutics details operations and product pipeline
Gyre Therapeutics posted an exhibit detailing its platform and clinical pipeline for protein degraders. The filing outlines plans to leverage China operations and specific development timelines for candidates like CG009301 and ETUARY™.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day